obesity tirzepatide (ZEPBOUND) Approved for Chronic Weight Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Tirzepatide outperforms semaglutide in weight

Youd have a 7-day washout period between medications, and your prescriber will advise on the appropriate Mounjaro starting dose based on your current Ozempic dose

Our goal is to guide you towards vibrant health and well-being, empowering you to overcome lifestyle habits that hold you back plus help you to improve your overall quality of life in addition to losing weight

Help with cellular respiration, a metabolic process that can speed up weight loss

Dose titration decisions are made by the Arora Health clinician based on your clinical response - not by Trimi's platform, and not by you

Incretinbased therapy of metabolic disease